Policy brief : Lymphatic filariasis (LF)
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Help
Clear All

Query Builder

Query box

Help
Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Policy brief : Lymphatic filariasis (LF)

Filetype[PDF-467.46 KB]


  • English
    • Details You May Also Like

    Details:

    • Corporate Authors:
      Center for Global Health (U.S.). Division of Parasitic Diseases and Malaria.
    • Description:
      To date, close to 700 million individuals in some of the poorest areas globally have received treatment to prevent one of the world’s most incapacitating diseases, lymphatic filariasis.

      Lymphatic filariasis (LF) is a disabling parasitic disease caused by microscopic worms that are spread from person-to-person by the bite of infected mosquitoes. The adult worms live in the human lymphatic system and can cause lymphedema (swelling) affecting the legs, arms, and breasts. They can also cause hydrocele (severe fluid accumulation) affecting the genitalia of men. The health impact of lymphatic filariasis usually appears many years after initial infection. LF causes chronic pain, severe and irreversible disfigurement, and social stigmatization. Treatment of communities where LF is transmitted can prevent new cases of disease.

      Lymphatic filariasis is one of the world’s Neglected Tropical Diseases (NTDs). This group of infectious diseases affects more than 1 billion persons and is responsible for tremendous physical and emotional suffering and economic loss. LF is recognized as one of the most disabling and economically costly NTDs, as infection with the disease can lead to lower productivity and inability to work. However, LF can be prevented, and eventually eliminated from the world, using inexpensive medications.

      CS250096

    • Subjects:
    • Document Type:
      Pamphlet (or booklet)
    • Collection(s):
    • Main Document Checksum:
    • Download URL:
    • File Type:

    Supporting Files

    • No Additional Files

    More +

    You May Also Like

    Checkout today's featured content at stacks.cdc.gov